Themis Medicare (THEMISMED)
FAST GROWERFairStock Score: 6/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹95.66 |
| Market Cap | ₹790.22 Cr |
| P/E Ratio | 0 |
| ROCE | 10.37% |
| ROE | -7.35% |
| Dividend Yield | 0.58% |
| Profit Growth | 1,000% |
| Debt/Equity | 0.25 |
| Sales Growth | -3.92% |
| Promoter Holding | 67.11% |
| 52-Week Range | ₹64.95 — ₹151.19 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹35.07 |
Themis Medicare trades with ROCE of 10.37%, ROE of -7.35%, profit growth of 1,000%, debt-to-equity of 0.25. The FairStock Score of 6/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer